Skip to content
Recall Observatory FDA recall evidence

Drug product

Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL), 16 fl. oz. (473 mL) bottle, Rx only, Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 27808-086-02.

D-1517-2019

July 11, 2019

Class II

Product summary

Firm
Tris Pharma Inc.
Event
Event 83346
Status
Terminated
Classification
Class II
Quantity
2,550 bottles
Official record key
drug-enforcement:D-1517-2019

Official wording

Reason: Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.

Code information: Lot#: 14079, Exp 10/2021

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent